Back

Risk of major cardiovascular events and bleeding in atrial fibrillation patients with chronic obstructive pulmonary disease treated with low dose azithromycin prophylaxis.

25 August 2023 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Remodelling, prognosis, and outcomes in atrial fibrillation Clinical ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Tommaso Bucci

University of Perugia, Perugia (Italy)

7 More presentations in this session

Presentation thumbnail
Duration of left and right atrial activation wavefront assessed non-invasively is significantly higher in patients with atrial fibrillation than in controls.
Doctor L. Parreira (Setubal, PT)
Abstract Slides Video
Presentation thumbnail
The risk and cause of death according to prevalent atrial fibrillation and the role of CHA2DS2-VASc score to stratify the risk of all-cause and cardiovascular death
Doctor Y. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Lower risk of atrial fibrillation development associated with SGLT-2 inhibitors in type 2 diabetic patients compared to DPP-4 inhibitors: a nationwide cohort study
Doctor J. Lee (Cheongju, KR)
Abstract Slides
Presentation thumbnail
Baseline demographic and clinical characteristics as predictors of adverse outcomes to improve management of patients with AF receiving edoxaban: a subanalysis of the ETNA-AF registry
Doctor D. Morrone (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation burden on longitudinal changes in left ventricular structure and function: a post-hoc analysis of a randomized clinical trial
Miss F. Vyff (Gentofte, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Remodelling, prognosis, and outcomes in atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August 2023 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Epidemiology and clinical impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: findings from an european prospective observational registry
thumbnail
Congress Presentation
Impact of chronic obstructive pulmonary disease on the natural history of atrial fibrillation: a report from the GLORIA-AF registry phase II & III
thumbnail
Congress Presentation
Atrial fibrillation-related complications following short-term use of antibiotics in patients receiving NOAC or warfarin

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources